Therapeutics Acquisition Corp

Therapeutics Acquisition Corp, trading under the ticker PNT, was a blank-check company formed to pursue an acquisition target in the healthcare and therapeutics sector. On January 8, 2024, the company filed a Form 15-12G with the SEC, certifying the termination of its registration under Section 12(g) of the Securities Exchange Act, marking the conclusion of its public reporting obligations. The 15-12G filing signals that PNT has exited its SPAC lifecycle, whether through a completed business combination or a wind-down, and its shares are no longer registered on a national exchange under that class. SpacDesk tracks the full filing history, sponsor details, and lifecycle data for Therapeutics Acquisition Corp and hundreds of similar vehicles — sign up at SpacDesk for complete SPAC intelligence.